tm
Seeing Is Believing
tm
Seeing Is Believing
BMRN is currently covered by 24 analysts with an average potential upside of $24.77 (28.53%) from yesterday's end of day stock price of $92.94. BioMarin Pharmaceutical activity chart has currently 358 price targets and 343 ratings on display.
Analysts average stock forecasts to be materialized ratio is 57.95% with an average time for these price targets to be met of 410.05 days.
Highest price target for BMRN is $115, Lowest price target is $72, average price target is $93.5.
Most recent stock forecast was given by MOHIT BANSAL from WELLS FARGO on 15-Nov-2023. First documented stock forecast 31-Mar-2009.
BioMarin Pharmaceutical . is a biotechnology company that specializes in the development and commercialization of therapies for rare and life-threatening diseases. The company’s main focus is on the development of therapies for patients with genetic disorders.
BioMarin’s commercial products include Vimizim, Naglazyme, Kuvan, Palynziq, Brineura, Voxzogo, and Aldurazyme, which are used for the treatment of various rare diseases such as mucopolysaccharidosis, phenylketonuria, and ceroid lipofuscinosis.
The company is also developing gene therapies for hemophilia A, Hereditary Angioedema, and primary hyperoxaluria.
BioMarin has license and collaboration agreements with other pharmaceutical companies, such as Sarepta Therapeutics, Ares Trading S.A., Catalyst Pharmaceutical Partners., and Asubio Pharma.
BioMarin Pharmaceutical Inc. was incorporated in 1996 and is headquartered in San Rafael, California.
Currently, out of the existing stock ratings of BMRN - 64 which are a Buy (77.11%), 19 which are a Hold (22.89%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
100
$5.06 (5.33%)
86
23 days ago
3/5 (60%)
$18.72 (22.23%)
119
Buy
100
$5.06 (5.33%)
102
1 months 5 days ago
1/4 (25%)
$9.01 (11.25%)
22
Buy
117
$22.06 (23.24%)
125
1 months 6 days ago
11/16 (68.75%)
$23.43 (26.81%)
158
Buy
111
$16.06 (16.92%)
125
1 months 6 days ago
4/7 (57.14%)
$23.88 (28.04%)
266
Buy
115
$20.06 (21.13%)
125
1 months 6 days ago
15/32 (46.88%)
$33.08 (39.58%)
452
What is BMRN (BioMarin Pharmaceutical) average time for price targets to be met?
Which analyst has the current highest performing score on BMRN (BioMarin Pharmaceutical) with a proven track record?
Which analyst has the most public recommendations on BMRN (BioMarin Pharmaceutical)?
Which analyst is the currently most bullish on BMRN (BioMarin Pharmaceutical)?
Which analyst is the currently most reserved on BMRN (BioMarin Pharmaceutical)?
